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Purpose: This study examines the impact of different modes of treatment on depression, anxiety, trau-
matic stress and quality of life in colorectal cancer patients and their partners.
Methods: The sample was comprised of 114 oncology patients and 67 partners. All patients were diag-
nosed with colorectal cancer. Participants were recruited from an Oncology Hospital in the North of
Portugal and had been submitted to three modes of treatment: surgery, surgery plus chemotherapy or
surgery followed by radiotherapy.
Results: The results showed that patients who received only surgery, as treatment, had lower levels of
depression, anxiety and traumatic stress symptoms when compared with patients who received surgery
and chemotherapy or surgery plus radiotherapy. Partners of surgical patients presented lower levels of
state anxiety and traumatic stress symptoms when compared with the other two groups. Patients with
more depression had partners also more depressed. No relationship was found between anxiety and
traumatic stress symptoms in patients and partners. Patients who received a diagnosis longer than 12
months had more traumatic stress, intrusion and hypervigilance. Patients with illness recurrence showed
more traumatic symptoms. Anxiety and depression were the main predictors of patient’s quality of life.
Traumatic stress was a predictor of symptom distress - pain/bowel pattern.
Conclusion: This study highlights the importance of providing psychological interventions for cancer
patients and their partners. Chemotherapy patients and those diagnosed over a year, as well as their
partners, are more at risk.
 2011 Elsevier Ltd. All rights reserved.Introduction
Colorectal cancer is the second leading cause of cancer mortality
in Western countries. Both sexes are equally affected by this
disease, however there is a higher incidence in people over ﬁfty
years. In Portugal, according to the National Oncology Register
(Pontes, 2005), the incidence of colon and rectum cancer is 33,4%
for females and 42,8% for males.
Many studies have linked colorectal cancer to economic condi-
tions, geographical location and diet (Imbembo and Lefour, 1993;
Belcher, 1996). Cancer often requires invasive treatments that
may affect body image, sexuality, physical and psychological well-
being (McCray, 2000; Wagner and Cella, 2004) and, consequently,
quality of life. The treatment of choice for colon and rectum cancer
is surgery (Ganzl, 1996; Santos, 1999; Murphy, 2000). Surgery,: þ351 253 6042224.
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uese patients and their parradiation therapy and chemotherapy are used to cure, prolong life
and to palliate symptoms in cancer patients. The hematological
malignancies and lympho-prolifaretive disorders are treated with
chemotherapy while in solid tumors, chemotherapy is used either
as adjuvant or neoadjuvant (Pandey et al., 2006). Chemotherapy
and radiation treatments have an impact on patient’s quality of life
due to treatments’ secondary effects (Couvreur, 2001; Hann et al.,
1998; Smith and Tchekmedyian, 2002) that can cause short and
long-term adverse effects resulting in health deterioration (Yost
et al., 2008).
Chronic illness not only affects the patient but also the couple
(Pereira and Lopes, 2002; Figueiredo et al., 2001; Santos, 1999).
Weihs and Reiss (1996) reported that insecure couple relationships
are more vulnerable to the effects of cancer when compared to safe
relationships that serve as a shield from the destructive impact of
cancer. Patient and partner go through a mourning process when
faced with cancer (Maden, 2006; Lopes, 1997). Some studies
document psychological morbidity and post-traumatic stress in
both cancer patients and their partners. Depression in patients isession, traumatic stress and quality of life in colorectal cancer after
tners, European Journal of Oncology Nursing (2011), doi:10.1016/
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2002). In fact, 29%e43% of cancer survivors with 14 different types
of cancer diagnosis have subclinical or clinical depression (Zabora
et al., 2001) and about 20%e25% experience major depressive
disorder. Patients with depression associated to cancer are at risk
for poorer health outcomes than those with cancer alone (Zabora
et al., 2001).
Maguire (1994) believes that anxiety and depressive symptoms in
partners are a result of the uncertainties related to cancer prognosis
and the possibility of death. For Bishop (1994) and Weitzner et al.
(1999), the impact of cancer in partners is associated to stress and
depression,withamagnitudeequal or greater than inpatients. In fact,
25% of partners, often suffer the same or higher levels of emotional
distress as cancer survivors (Badger et al., 2007). Blanchard et al.
(1997) reported that the percentage of partners who present mood
disturbances and psychological deterioration ranges from 20 to 30%
compared to cancer patients.
Cancer has certain features that may contribute to the devel-
opment of post-traumatic stress disorder (PTSD). In fact, the diag-
nosis, treatments with adverse side effects, follow-up exams and
the possibility of relapse, require the patient and partner to be
continually exposed to memories of the life threatening nature of
the disease and its symptoms (Passik and Grummon, 1998; Potash
and Breibart, 2002). Cancer is associated with a threat to physical
integrity and its sudden, unpredictable, often irreversible features
are associated to a loss of an healthy identity, signiﬁcant factors that
may contribute to post-traumatic stress disorder (Andrykowski and
Cordova, 1998; Perez and Galdón, 2002). PTSD symptoms can arise
at various stages of the disease including diagnosis (Roth and
Breitbart, 2001).
Different types of treatment have a different impact on patients.
Surgical treatments are often associated with mutilation, particu-
larly if important organs are involved like the intestinal organ
(Gaecia et al., 1996; Santos, 1999). The possible loss of autonomy,
often associated with the feeling of burden, disrupts patient’s
quality of life (Santos, 1995; Demetri, 2001; Hurter and Bush, 2007).
Several studies have assessed the impact of different treatments on
patient’s quality of life (Schmidt et al., 2005; Pollack et al., 2006).
Patients going through radiotherapy reported having more pain
than non-radiated patients. Those patients who received chemo-
therapy presented problems on cognitive function, pain and
appetite loss that were associated to type of protocol received
(Nicolussi and Sawada, 2009).
In light of the above considerations, this paper assesses the
inﬂuence of treatment (i.e. surgery; surgery and chemotherapy;
surgery and radiotherapy) in patients with colorectal cancer and
their partners, on quality of life, depression, anxiety and traumatic
stress symptoms. The authors hypothesized that there would be
differences among the three groups, in both patients and partners,
expecting the group that received only surgery to have lower levels
of psychological morbidity in all three measures when compared to
other treatment modalities. The authors also predict a positive
relationship between psychological morbidity (depression, anxiety
and traumatic stress symptoms) in patients and partners regardless
of patients’ treatment. Finally, the authors were interested in
ﬁnding out the best predictors of self reported quality of life in
patients.
Methodology
Sample
141 patients (62% males and 38% females) and 67 partners (39%
males and 61% females) participated in the study. All patients were
diagnosed with colorectal cancer. Participants were recruited fromPlease cite this article in press as: Graça Pereira, M., et al., Anxiety, depr
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divided in three groups: Group A included 35 patients who received
only surgical treatment and 19 partners; group B consisted of 41
patients who received treatment of surgery followed by chemo-
therapy and 26 partners; group C included 38 patients who
received surgery followed by radiotherapy and 22 partners.
42% of patients and 28% of partners had ﬁnished primary school,
22% of patients and 6% of partners had ﬁnished high school. Only
18% of patients and 22% of partners had more than 9 years of
schooling. Only 9% of patients were active.
48% of patients had received a cancer diagnosis longer than
a year and 29% received treatment for cancer recurrence.
Procedure
During the period of 12 months, after receiving the list of
patients who underwent chemotherapy, radiotherapy or surgery,
one of the authors invited patients and partners to participate in
the study when they visited, during that year, the physician for
their regular hospital follow-up appointments. Patients and part-
ners, who agreed to participate, completed questionnaires in
separate rooms after ﬁlling the informed consent. Due to the fact
that some patients had no partners, there was a signiﬁcant differ-
ence in the number of partners and patients in the study. In addi-
tion, partners with cancer were excluded from the study.
Instruments
Patients
Anxiety and depression were assessed by the Hospital Anxiety
and Depression Scale (HADS), (Zigmond & Snaith, 1983). The scale
has 14 items. Reliability for the adapted version (Pereira and
Figueiredo, 2008) is 0.94. The anxiety subscale has an alpha of .91
and the depression subscale an alpha of 0.88. Cut off scores for
clinical depression in cancer patients has been set at 5, clinical
anxiety at 7 and psychological morbidity (total scale) at 13 (Singer
et al., 2009). Higher scores indicate higher morbidity.
Quality of life was assessed with the Quality of Life Scale- Cancer
(QOL-CA2), (Padilla et al., 1983). QOL-CA has 30 items and ﬁve
subscales: Existential Well-Being, Physical Functional Well-Being,
Symptoms Distress-Nutrition, Attitude of Worry and Symptom
Distress-Pain/Bowel Pattern. Reliability for the Portuguese version
(Pereira and Figueiredo, 2005) was 0.94 for the total scale and the
alpha ranged from 0.80 to 0.90 for subscales except for the subscale
“attitude of worry” that had an alpha of 0.66 but due to the fact that
has only three items, it is considered acceptable (Nunnally, 1978).
High scores indicate less quality of life.
Partners
Due to the fact that HADS was not adapted in non-clinical
Portuguese samples, depression was assessed with the Beck
Depression Inventory (BDI), (Beck et al., 1961). The scale includes 20
items. Reliability for the Portuguese adapted version (McIntyre and
McIntyre, 1995a) is 0.89. In the Portuguese version, cut off scores
have been set by Gouveia (1990) at: 0 to 9 (absence of depression),
10 to 30 (moderately depressed) and above 30 (severely
depressed). Higher scores indicate more depression.
Anxiety was evaluated with the State Trait Anxiety Inventory
(STAI), (Spielberger et al., 1983). The scale has 40 items, 20 for state
anxiety and 20 for trait anxiety. The Portuguese Version (McIntyre
and McIntyre, 1995b) showed an alpha of 0.79 for Trait Anxiety and
0.94 for State Anxiety. A mean score above 35.2, for active adults, isession, traumatic stress and quality of life in colorectal cancer after
tners, European Journal of Oncology Nursing (2011), doi:10.1016/
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indicate more anxiety.
Finally, patients and partners completed the Impact of Events
Scale Revised (IES-R), (Weiss & Marmer, 1977). The scale has 22
items. A cut off score of 33 indicates probable PTSD (Creamer et al.,
2003). The Portuguese adapted version (Pereira and Figueiredo,
2008) for patients showed a reliability of 0.90 (total scale), for the
subscale “Intrusion” an alpha of 0.91, for “Hypervigilance” 0.89 and,
ﬁnally, for “Avoidance” 0.70. In partners, reliability for the total
instrument was 0.90, and for Intrusion 0.90, for Hypervigilance,
0.82 and, ﬁnally, for Avoidance 0.75. Higher scores indicate more
traumatic symptoms.
Data analysis
Differences among groups were tested using MANOVA and,
when appropriate, Scheffé tests were performed. Listwise deletion
was used for the analysis that included both patients and partners
to ensure that there would be equal numbers. The relationship
between depression, anxiety and PTSD in patients and partners was
analyzed using Pearson correlations. Differences among patients,
according to diagnosis duration and cancer recurrence, were
assessed by Manova in the ﬁrst case and a t test in the second since
the corollaries for parametric statistics were present (the distri-
bution was normal and variance was controlled assuming unequal
variances among the groups in both tests). Regression analysis was
used to determine the predictors of quality of life (stepwise
method). The variables included in the model were anxiety,
depression and traumatic stress symptoms since they were all
correlated with quality of life (dependent variable).
Results
Differences in anxiety, depression and post-traumatic stress
symptoms in patients and partners according to treatment
The results showed signiﬁcant differences in anxiety, depression
and traumatic stress symptoms among the three groups (Table 1).
Scheffé tests showed that patients who undergone surgery/
chemotherapy had more anxiety (p  0.001), more depression
(p  0.005) and more traumatic symptoms (p  0.001) when
compared to the surgical group. Patients who went through
surgery/radiotherapy, compared to surgical patients, presented
more anxiety (p  0.006), more depressive symptoms (p  0.041)
and more traumatic symptoms (p  0.001). No differences were
found between the groups surgery/chemotherapy and surgery/
radiotherapy in all three measures.Table 1
Results of Manova in patients with colorectal cancer (n ¼ 141) and partners (n ¼ 67)
according to treatment.
Patients Surgery
mean
(n ¼ 35)
Surgery/
Chemotherapy
mean (n ¼ 41)
Surgery/
Radiotherapy
mean (n ¼ 38)
F p
Anxiety (HADS) 5,97 10,41 9,73 8,57 <0.001
Depression (HADS) 5,42 9,02 8,26 5,93 0.004
Traumatic Stress
(IES-R)
6,92 8,80 8,62 12,76 <0.001
Partners (n ¼ 19) (n ¼ 26) (n ¼ 22) F p
State Trait Anxiety
Inventory (STAI)
40,68 44,36 42,95 1,13 0.329
State Trait Anxiety
Inventory (STAI)
42,68 54,61 50,04 4,69 0.012
Depression (BDI) 10,47 13,61 10,81 0,98
Traumatic Stress
(IES-R)
7,00 8,59 8,07 3,83 0.027
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(state) and traumatic stress symptoms according to treatment.
Partners of surgical patients presented lower levels of state anxiety
and traumatic stress when compared with partners of the other
two groups. Scheffé tests revealed that surgical patients had
signiﬁcant less anxiety (p < 0.013) and traumatic stress (p < 0.028)
than the surgery/chemotherapy group. No differences were found
in partners of patients who received surgery/radiotherapy
compared to partners of patients who received surgery/chemo-
therapy. Table 1 shows the results for both patients and partners.
Differences in traumatic stress symptoms according to diagnosis
duration and recurrence
A signiﬁcant difference on global traumatic stress was found in
patients according to diagnosis duration. Patients with a diagnosis
over a year presented more global traumatic stress, intrusion and
hypervigilance. Scheffé tests showed that this group (group 1) had
more traumatic stress than those with less than a six months
diagnosis (p < 0.006) (group 3) and also from those with a diag-
nosis between six months and a year (group 2), (p < 0.004). In
terms of traumatic stress clusters, group 3 hadmore avoidance than
group 1 (p < 0.002) and 2 (p < 0.016) but less intrusion than group
1 (p < 0.001) and 2 (p < 0.001) as well as less hypervigilance than
group 1 (p < 0.001) and 2 (p < 0.004). Table 2 shows the results.
29% of patients reported they had received treatment for
a cancer recurrence. Signiﬁcant differences were found in traumatic
stress between the group of patients with recurrence versus no
recurrence with the ﬁrst one showing more traumatic stress that
the other group (t ¼ 7.14, p < 0.001). No differences were found in
traumatic stress, in the recurrence group, by type of treatment.
Regarding depression and anxiety no differences were found in
the two groups.
Relationship between depression, anxiety and PTSD in patients and
partners
Results showed that the only signiﬁcant variable that was
associated in patients and partners was depression (r ¼ 0.287;
p ¼ 0.021). Depressed patients seem to have depressed partners
and vice-versa. No differences were found on anxiety and traumatic
stress between patients and partners.
Predictors of quality of life
Anxiety and depression predicted overall quality of life,
explaining 78.4% of variance. In terms of quality of life domains:
anxiety and depression predicted psychosocial existential well-
being explaining 63,6% of variance and physical functional well-
being explaining 76.7% of the variance.
Anxiety alone predicted symptoms distress-nutrition and atti-
tude of worry, explaining respectively, 27.6% and 43.6% of the
variance. Finally, traumatic stress and anxiety together predicted
symptoms distress - paid bowel pattern, explaining 51% of the
variance. Table 3 shows the results.Table 2
Results of Manova on PTSD in patients according to Diagnosis duration (n ¼ 141).
Post-traumatic stress Means F p
<6 months
(n ¼ 31)
6 months to
1 year (n ¼ 29)
>1 year
(n ¼ 54)
IES-R 7,54 7,47 8,16 8173 <0.001
IES-R - Avoidance 3,09 2,41 2,60 7030 0.001
IES-R - Intrusion 2,33 2,54 3,20 15,461 <0.001
IES-R - Hypervigilance 2,11 2,51 3,07 10,59 <0.001
ession, traumatic stress and quality of life in colorectal cancer after
tners, European Journal of Oncology Nursing (2011), doi:10.1016/
Table 3
Predictors of quality of life (n ¼ 141).
Standardized betas
Total Quality
of life
Quality of life: Psychosocial
existential well-being
Quality of life: Physical
functional well-being
Quality of Life: Symptom
distress - nutrition
Quality of Life: Symptom
distress - pain/bowel pattern
Quality of life: Attitude
of worry
Anxiety 0.472*** 0.449*** 0.662*** 0.525*** 0.514*** 0.661***
Depression 0.454*** 0.385*** 0.245**
Traumatic Stress 0.271**
R2 Adjust 0.784 0.636 0.767 0.276 0.510 0.436
**p < 0.01; *p < 0.05; ***p < 0.001.
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Results showed that patients and partners displayed symptoms
of anxiety, depression and traumatic stress symptoms. In fact,
cancer is considered one of the most feared illnesses in the general
population causing several emotional reactions (Murard, 1996;
Figueiredo et al., 2001; Santos, 2003). Cancer affects the partner,
since it requires a change in the couple’s organization of daily life
and interpersonal relationships (Wagner and Cella, 2004).
Results are in accordance with the literature showing patients,
who experienced surgery, and their partners, to have lower levels
of traumatic stress and psychological morbidity when compared to
the other two groups. In fact, patients who experienced surgery/
chemotherapy and surgery/radiotherapy have more treatment side
effects and, as a result, more suffering, more trips to the hospital
and more periods of in patient treatment than surgical patients and
these factors may have contributed to more psychological
morbidity (Denlinger and Barsevick, 2009). Surgical patients
showed only minor levels of anxiety, depression and post-
traumatic stress symptoms. Although not signiﬁcant, depression
and post-traumatic stress were higher in patient who received
chemotherapy versus radiotherapy indicating that these patients
may be more at psychological risk.
Cancer patients are different from other individuals who expe-
rienced other types of trauma i.e. singular events that have stopped.
Cancer patients, on the other hand, since their ongoing medical
follow-up visits, are surrounded by the realistic fear of disease’s
recurrence and other medical problems or hospitalization
(Duhamel et al., 2000). Given these unavoidable, recurrent expo-
sures to these trauma related triggers, it comes as no surprise that
cancer patients who received chemotherapy or radiotherapy
perceive their cancer as more severe and, as a result, showed more
traumatic stress symptoms.
Patients who received a diagnosis longer than a year showed
more traumatic stress symptoms since the threat for recurrence
becomes more real. According to literature, newly diagnosed
patients with cancer often respond more with sadness, anxiety or
develop depression (Bush, 2008). Traumatic stress, on the other
hand, requires a longer course of illness. In fact, research shows that
only 3%e4% of patients with early-stage cancer meet full PTSD
criteria, but it gets as high as 35% in patients evaluated after
treatment (NCI, 2009). On the other hand, 20% of cancer survivors
with early-stage disease and 80% of patients diagnosed with
recurrence may have “partial” PTSD symptoms (Knobf, 2007;
Shelby et al., 2008).
Lower levels of traumatic stress, anxiety and depression were
reported in surgical patients compared to the other two groups. In
surgical patients, PTSD-associated symptoms may be related to the
trauma itself and/or surgical intervention. Experiences due to
treatment in the ICU, such as pain, lack of control and inability to
express needs were predictors of psychological distress symptoms
a short time after ICU discharge (Myhren et al., 2009). However, in
radiotherapy and chemotherapy patients have even less controlPlease cite this article in press as: Graça Pereira, M., et al., Anxiety, depr
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appraisal of their cancer may explain why traumatic stress symp-
toms are higher in these two groups.
In partners, differences were found in anxiety state and post-
traumatic stress i.e. partners of patients who went through
surgery when compared with the other two groups showed less
anxiety and traumatic stress. These results may be due to treat-
ment’ side effects that are less intense in surgery and, therefore,
have a lower impact in the partner (Bartelink et al., 2002) as well.
Depression was the only signiﬁcant variable correlated in
patients and partners. These results are in accordance with some
literature that has shown partners to have higher anxiety than
cancer patients but did not differ on depressive symptoms (Manne
et al., 2003). Partners’ anxiety has also been associated to depres-
sion and fatigue in patients with breast cancer (Segrin et al., 2007).
In fact, studies have shown an association between patient and
partners’ distress i.e. partners’ distress reactions are closely linked
to patients. The close relationship found between patient and
partners’ depression provides some support for the concept of
“couples at risk”, deﬁned as a pattern of highehigh distress in both
partners (Keller et al., 1996). This result is interesting because
highlights the importance of psychological intervention, after
cancer treatment, besides the initial phase of diagnosis. Therefore,
early identiﬁcation of high-risk couples is critical. Psychological
interventions designed to help cancer patients reduce their
depression may ultimately contribute to reduce partners’ depres-
sion that compromise their ability to provide the needed support
that would help the patient to adjust better to treatment.
Anxiety and depression were signiﬁcant predictors of quality of
life. In fact, cancer treatment (surgery, chemotherapy, radio-
therapy), with its collateral side effects produce physical and
emotional disturbances that inﬂuence quality of life (Holland et al.,
1986; Hacpille, 2000). Interestingly, anxiety and traumatic stress
symptoms predicted symptom distress - pain/bowel pattern and
this is the only dimension of quality of life predicted by traumatic
symptoms. This result may have to do with colon pain that patients
may feel directly related to less quality of life since pain impacts
patients’ daily activities and, as a result, may be related to traumatic
symptoms (Couvreur, 2001). Also, traumatic symptoms may be
associated to fears of mutilation and a consequent uncertain future
due to the possible need of an ostomy.
In conclusion, this study highlights the importance of providing
psychological interventions for cancer patients and their partners.
Chemotherapy patients and those diagnosed over a year are more
at risk.
Limitations
The use of self reported measures, the fact that patients were all
recruited in one institution and the small number of partners limit
the generalization of these ﬁndings.
Future studies should determine how patients and partners’
illness representations relate to traumatic stress symptoms andession, traumatic stress and quality of life in colorectal cancer after
tners, European Journal of Oncology Nursing (2011), doi:10.1016/
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amediator in the relationship between psychological morbidity, (in
partners), and quality in life (in patients). It will be also important
to include illness stage, coping mechanisms and previous experi-
ence of trauma as moderating factors.
Finally, it would be important to study the impact of patients
and partners’ gender and age on psychological morbidity control-
ling for disease relapse.Conclusion
The present study revealed differences in colorectal patients and
their partners in psychological morbidity according to different
types of treatment. According to results, patients who received
chemotherapy are more at risk than the other two groups.
Psychiatric symptoms ranging from anxiety and depression to
PTSD can interfere with patient functioning, including compliance
with oncologic treatments and follow-up examinations, family and
social relationships, and occupational roles. As a result, greater
understanding of factors that may predict cancer-speciﬁc distress
could enable better clinical or psychoeducational interventions.
Educating the patient and family regarding diagnosis and
treatment is invaluable. Hospitals should provide interventions to
help patients and partners adapt to cancer and go through the
illness’ stages in order to promote their quality of life. Health
professionals should also be attuned for signs of clinical distress
and screen patients and partners who are most in need of
psychological help. For some patients and partners, psychotherapy
may be necessary and should be one of the options available.
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